Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

DXCM holding history

Dexcom Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
103,444
Value
$6.97M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DXCM by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026103,444$6.97M<0.1%−2,644−2.5%ReducedHolders
Q1 2026106,088$6.66M<0.1%+8,168+8.3%AddedHolders
Q4 202597,920$6.50M<0.1%+5,021+5.4%AddedHolders
Q3 202592,899$6.25M<0.1%−1,094−1.2%ReducedHolders
Q2 202593,993$8.20M0.1%+3,771+4.2%AddedHolders
Q1 202590,222$6.16M0.1%+1,023+1.1%AddedHolders
Q4 202489,199$6.94M0.1%−948−1.1%ReducedHolders
Q3 202490,147$6.04M0.1%+687+0.8%AddedHolders
Q2 202489,460$10.1M0.1%+2,141+2.5%AddedHolders
Q1 202487,319$12.1M0.1%+1,594+1.9%AddedHolders
Q4 202385,725$10.6M0.1%−2,878−3.2%ReducedHolders
Q3 202388,603$8.27M0.1%+1,701+2.0%AddedHolders
Q2 202386,902$11.2M0.1%+1,842+2.2%AddedHolders
Q1 202385,060$9.88M0.1%+1,245+1.5%AddedHolders
Q4 202283,815$9.49M0.2%+5,389+6.9%AddedHolders
Q3 202278,426$6.32M0.1%−429−0.5%ReducedHolders
Q2 202278,855$5.88M0.1%−2,005−2.5%ReducedConverted for a 4-for-1 splitHolders
Q1 202220,215$10.3M0.2%+214+1.1%AddedHolders
Q4 202120,001$10.7M0.2%+5,242+35.5%AddedHolders
Q3 202114,759$8.07M0.2%−417−2.7%ReducedHolders
Q2 202115,176$6.48M0.1%+1,479+10.8%AddedHolders
Q1 202113,697$4.92M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.